Dr. Anne Marijn Kramer, MD, PhD, is a postdoctoral research fellow in the Division of Blood and Marrow Transplantation and Cellular Therapy at Stanford University. Dr. Kramer received her medical degree (with honors) from Amsterdam University in 2013. She conducted her PhD studies at University College London, studying binding kinetics of Chimeric Antigen Receptor (CAR) T cells. Her research at Stanford University focuses on developing methods to identify patients who are at high risk for relapse or developing side-effects after receiving CAR T therapy and to understand why these relapses and side-effects occur.

Honors & Awards

  • ASH abstract achievement award, American Society of Hematology (12/09/2023)
  • EHA Junior Research Grant, European Hematology Association (09/01/2022)
  • Paul Fentener van Vlissingen Fellowship, Lymph&Co (09/01/2022)
  • Prins Bernhard Cultuurfondsbeurs, Prins Bernhard Cultuurfonds (06/01/2013)
  • VSBfonds beurs, VSBfonds (06/01/2013)
  • NIHR GOSH/UCL ICH BRC PhD Scholarship, NIHR Great Ormond Street Hospital/UCL Institute of Child Health Biomedical Research Centre (04/01/2014)
  • CCA grant co-applicant, Cancer Center Amsterdam (03/01/2020)

Boards, Advisory Committees, Professional Organizations

  • President, Dutch Junior Society of Internal Medicine (2020 - 2021)
  • Board Member, Dutch Society of Internal Medicine (2020 - 2021)

Professional Education

  • Doctor of Medicine, Universiteit Van Amsterdam (2013)
  • Diploma, Stedelijk Gymnasium Johan van Oldenbarnevelt (2005)
  • Doctorandus, Universiteit Van Amsterdam (2011)
  • Doctor of Philosophy, University College London (2017)
  • PhD, University College London, Cancer Immunotherapy (2017)
  • MD, University of Amsterdam, Medicine (2013)

Stanford Advisors


  • Kramer AM, Kokalaki E, Pule MA. "United KingdomOff-rate CAR", UCLB, Sep 1, 2016
  • Mekkaoui L, Kramer AM, Ghorashian S, Pule MA. "United KingdomA CAR against CD19 based on a novel binder", UCLB, Mar 1, 2015